Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer

NCT01047358 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01047358
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01047358 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post Marketing Surveillance Study To Observe Safety And Efficacy Of Aromasin In The Patients With Early Or Advanced Breast Cancer
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
June 30, 2010
Completion date
June 30, 2014
Enrollment
206 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer